|
Volumn 50, Issue SUPPL. 2, 2009, Pages 1-3
|
Posttraumatic epilepsy: Treatable epileptogenesis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ANTICONVULSIVE AGENT;
APOPTOSIS INHIBITOR;
CALCIUM CHANNEL BLOCKING AGENT;
CASPASE INHIBITOR;
GLUTAMATE RECEPTOR ANTAGONIST;
GLUTAMIC ACID;
ION CHANNEL;
NEUROTRANSMITTER RECEPTOR;
NEUROTROPHIC FACTOR;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DIFFUSION TENSOR IMAGING;
DISEASE ASSOCIATION;
DISEASE MARKER;
DISEASE SEVERITY;
EDITORIAL;
EPILEPTOGENESIS;
GENE EXPRESSION;
HUMAN;
LATENT PERIOD;
NERVE CELL NETWORK;
NEUROIMAGING;
NEUROPHYSIOLOGY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSTTRAUMATIC STRESS DISORDER;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SEIZURE;
STEM CELL TRANSPLANTATION;
TRAUMATIC BRAIN INJURY;
TRAUMATIC EPILEPSY;
ANIMAL;
BRAIN;
BRAIN INJURY;
DISEASE MODEL;
DRUG EFFECT;
ELECTROENCEPHALOGRAPHY;
PATHOPHYSIOLOGY;
PROGNOSIS;
ANIMALS;
ANTICONVULSANTS;
BRAIN;
BRAIN INJURIES;
DISEASE MODELS, ANIMAL;
ELECTROENCEPHALOGRAPHY;
EPILEPSY, POST-TRAUMATIC;
HUMANS;
PROGNOSIS;
|
EID: 58849085451
PISSN: 00139580
EISSN: 15281167
Source Type: Journal
DOI: 10.1111/j.1528-1167.2008.02003.x Document Type: Editorial |
Times cited : (34)
|
References (13)
|